|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
CHEIL BIO CO.,LTD.
Main Activities: Pharmaceutical and Medicine Manufacturing
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name CHEIL BIO CO.,LTD. Headquarters 456-2, MONGNAE-DONG, DANWON-GU, ANSAN-SI, GYEONGGI-DO; Ansan; Gyeonggi; 425100 |
Status: Listed Legal Form: Public Limited Company Operational Status: Operational Financial Auditors: INDEOK (2011) Incorporation Date: January 1, 1989 Total Employees: 53 Tel: 031-494-8226-7 |
|
Company Description |
| The sales is going down due to the reduced sales of the functional additives for the animal feed amid the slowdown of the livestock businesses. The operating loss is recorded due to the increased sales and administration cost but the current net loss is not recorded due to the gain on the disposition of the tradable securities. It has a stable financing structure based on the affluent liquidity with no borrowing. It has a stable technology as it is producing the raw material in its own factory | ||
|
||
Company Analysis |
| According to the Individual - Audited financial statement for the first half of 2012, total net operating revenues increased with 34.53%, from KRW 12,525,039 thousands to KRW 16,850,163 thousands. Operating result increased from KRW 297,169 thousands to KRW 468,938 thousands which means 57.80% change. The results of the period increased 48.98% reaching KRW 576,827 thousands at the end of the period against KRW 387,193 thousands last year. Return on equity (Net income/Total equity) went from 2.54% to 3.62%, the Return On Asset (Net income / Total Asset) went from 2.07% to 2.59% and the Net Profit Margin (Net Income/Net Sales) went from 3.09% to 3.42% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 39.63% compared to 22.67% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 4.39 to 2.72 when compared to the previous year. |
Key Executives |
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
Companies with Similar Main Activities |
FULL COMPANY PROFILE
|
|
2012 Y (non-cons) |
2012 H1 (non-cons) |
|
 | ||
| Audited | Audited | |
| ||
| KR listed company financials | KR listed company financials | |
| ||
| Unit | Thousands | Thousands |
| ||
Balance Sheet
| ||
Total Assets |
23,485,363 |
22,228,709 |
| ||
Current Assets |
16,238,183 |
14,543,921 |
| ||
Total Liabilities |
7,268,003 |
6,308,537 |
| ||
Shareholders Equity |
16,217,360 |
15,920,172 |
| ||
Current Liabilities |
5,796,913 |
5,352,158 |
| ||
| * All the accounts are in KRW. | ||
Income Statement
| ||
Total Operating Revenue |
36,868,183 |
16,850,163 |
| ||
Operational Profit (Loss) |
861,200 |
468,938 |
| ||
Net Profit (Loss) |
1,026,456 |
576,827 |
| ||
| * All the accounts are in KRW. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Assets (ROA) |
4.37% |
2.59% |
| ||
Return on Equity (ROE) |
6.33% |
3.62% |
| ||
Return on Sales (ROS) |
2.78% |
3.42% |
| ||
Return on Capital |
5.8% |
3.42% |
| ||
Gross Profit Margin |
10.24% |
12.15% |
| Efficiency Ratios | ||
| ||
Current asset turnover |
2.27x |
1.16x |
| ||
Asset Turnover |
1.57x |
0.76x |
| Valuation figures and ratios | ||
| ||
Earning Before Interests and Taxes (EBIT) |
959,712 |
570,747 |
| ||
EBITDA |
861,200 |
468,938 |
| ||
Bookvalue (BV) |
16,212,260 |
15,915,072 |
| Liquidity Ratios | ||
| ||
Current Ratio |
280.12% |
271.74% |
| ||
Quick ratio |
183.39% |
160.97% |
| ||
Doom's day ratio |
28.65% |
36.24% |
| ||
Cash Flow to Debt |
3.68% |
8.67% |
| Leverage Ratios | ||
| ||
Leverage ratio |
144.82% |
139.63% |
| ||
Interest Coverage Ratio |
3,672.89% |
9,587.29% |
| ||
Debt to equity |
44.82% |
39.63% |
| ||
Debt to total assets |
30.95% |
28.38% |
| ||
Long Term Debt to Capital |
8.32% |
5.67% |
| Market ratios | ||
| ||
Price/Book Ratio |
0.95 |
0.82 |
| Trend Ratios | ||
| ||
Revenue Trend |
144.03% |
134.53% |
| ||
Net Income Trend |
170.12% |
148.98% |
| ||
 |